Using Data from the Canadian Post-marketing Spontaneous Pharmacovigilance System for Drug Safety Research: A Feasibility Study.
Samuel AkinolaCarolina Galli da SilveiraSonia CorbinMaude LavalléeMagalie ThibaultJennifer GonellaFernanda Raphael Escobar GimenesJacinthe LeclercPublished in: Pharmaceutical medicine (2021)
It seems feasible to use data from the Canadian Post-marketing Spontaneous Pharmacovigilance System for academic drug safety research. Upcoming studies should validate the quality of reports compared to actual medical charts.